Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DIO is a South Korean dental medtech company focused on dental implants, digital implant workflows, and broader digital dentistry solutions. The company develops and manufactures implant systems, guided surgery solutions, UV-treated implant products, digital prosthetic solutions, and digital orthodontic offerings. Its flagship DIOnavi platform supports computer-guided implant planning and placement, including full-arch workflows, while the company also markets related materials, equipment, and training. DIO operates internationally through a broad sales and subsidiary network and is publicly traded in Korea. The business is commercial-stage rather than a therapeutic drug developer, with revenues driven by dental implant products and digital dental solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIO Corporation.